Miloudi Hadjer, Bohers Élodie, Guillonneau François, Taly Antoine, Gibouin Vincent Cabaud, Viailly Pierre-Julien, Jego Gaëtan, Grumolato Luca, Jardin Fabrice, Sola Brigitte
INSERM U1245, Unicaen, Normandie University, F-14000 Caen, France.
INSERM U1245, Unirouen, Normandie University, and Centre de lutte contre le Cancer Henri Becquerel, F-76000 Rouen, France.
Cancers (Basel). 2020 Sep 30;12(10):2829. doi: 10.3390/cancers12102829.
The gene encodes exportin 1 (XPO1) that controls the nuclear export of cargo proteins and RNAs. Almost 25% of primary mediastinal B-cell lymphoma (PMBL) and classical Hodgkin lymphoma (cHL) cases harboured a recurrent point mutation (NM_003400, chr2:g61718472C>T) resulting in the E571K substitution within the hydrophobic groove of the protein, the site of cargo binding. We investigated the impact of the mutation using PMBL/cHL cells having various statuses and CRISPR-Cas9-edited cells in which the E571K mutation was either introduced or knocked-out. We first confirmed that the mutation was present in both XPO1 mRNA and protein. We observed that the mutation did not modify the export capacity but rather the subcellular localisation of XPO1 itself. In particular, mutant XPO1 bound to importin β1 modified the nuclear export/import dynamics of relevant cargoes.
该基因编码输出蛋白1(XPO1),它控制货物蛋白和RNA的核输出。近25%的原发性纵隔B细胞淋巴瘤(PMBL)和经典型霍奇金淋巴瘤(cHL)病例存在一个复发性点突变(NM_003400,chr2:g61718472C>T),导致该蛋白疏水凹槽内的E571K替换,该区域是货物结合位点。我们使用具有不同状态的PMBL/cHL细胞以及通过CRISPR-Cas9编辑的细胞(其中引入或敲除了E571K突变)来研究该突变的影响。我们首先证实该突变存在于XPO1的mRNA和蛋白中。我们观察到该突变并未改变输出能力,而是改变了XPO1自身的亚细胞定位。特别是,与输入蛋白β1结合的突变型XPO1改变了相关货物的核输出/输入动态。